Efficacy of Three Toothpastes Using an in Situ Caries Model

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

July 1, 2016

Study Completion Date

August 11, 2016

Conditions
Dental Caries
Interventions
DRUG

0.425 % w/w phytate,1150ppm F

Participants were assigned with 1.5±0.1g twice daily dentifrice for one timed minute.

DRUG

0.85 % w/w phytate,1150ppm F

Participants were assigned with 1.5±0.1g twice daily dentifrice for one timed minute.

DRUG

0.85 % w/w phytate,0.3%ZnCl2 0.5% sodium citrate, 1150ppm F

Participants were assigned with 1.5±0.1g twice daily dentifrice for one timed minute.

OTHER

0 ppm F

Participants were assigned with 1.5±0.1g twice daily dentifrice for one timed minute.

DRUG

1150ppm F

Participants were assigned with 1.5±0.1g twice daily dentifrice for one timed minute.

DRUG

0.3%ZnCl2, 0.5% sodium citrate, 1150ppm F

Participants were assigned with 1.5±0.1g twice daily dentifrice for one timed minute.

Trial Locations (1)

46202

GSK Investigational Site, Indianapolis

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY